T A Splinter|T C Kok - JoVE Visualize

Showing results (91-100 of 103) with videos related to

Pageof 11

Sort By:

Cancer|July 1, 1993

Influence of radiologically and cytologically assessed distant metastases on the survival of patients with esophageal and gastroesophageal junction carcinoma. The Rotterdam Esophageal Tumor Study GroupH van Overhagen, M Y Berger, H Meijers, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancerR de Wit, M Tesselaar, T C Kok, et al.

Journal of Neurology|June 1, 1994

The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trialJ M van Gerven, A Hovestadt, J W Moll, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupG Giaccone, T A Splinter, C Debruyne, et al.

Oncology|January 1, 1992

Multicenter phase II study of spiroplatinB C Tanis, J B Vermorken, W W ten Bokkel Huinink, et al.

European Journal of Cancer (Oxford, England : 1990)|February 5, 2003

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal GroupJ Wils, G H Blijham, Th Wagener, et al.

International Journal of Oral and Maxillofacial Surgery|April 18, 2024

An insight into clinicians' practices in breaking bad news of oral cancer diagnosisS N F Mohd Desa, J G Doss, K Kadir, et al.

European Journal of Cancer (Oxford, England : 1990)|February 21, 1998

Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative GroupT Sahmoud, P E Postmus, C van Pottelsberghe, et al.

The Journal of Urology|August 1, 1989

Phase II study of recombinant interferon alpha-2a and vinblastine in advanced renal cell carcinomaJ H Schornagel, J Verweij, W W ten Bokkel Huinink, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998

Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trialC Grimaldi, H Bleiberg, F Gay, et al.

Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:

Pageof 11

Cancer|July 1, 1993

Influence of radiologically and cytologically assessed distant metastases on the survival of patients with esophageal and gastroesophageal junction carcinoma. The Rotterdam Esophageal Tumor Study GroupH van Overhagen, M Y Berger, H Meijers, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancerR de Wit, M Tesselaar, T C Kok, et al.

Journal of Neurology|June 1, 1994

The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trialJ M van Gerven, A Hovestadt, J W Moll, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupG Giaccone, T A Splinter, C Debruyne, et al.

Oncology|January 1, 1992

Multicenter phase II study of spiroplatinB C Tanis, J B Vermorken, W W ten Bokkel Huinink, et al.

European Journal of Cancer (Oxford, England : 1990)|February 5, 2003

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal GroupJ Wils, G H Blijham, Th Wagener, et al.

International Journal of Oral and Maxillofacial Surgery|April 18, 2024

An insight into clinicians' practices in breaking bad news of oral cancer diagnosisS N F Mohd Desa, J G Doss, K Kadir, et al.

European Journal of Cancer (Oxford, England : 1990)|February 21, 1998

Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative GroupT Sahmoud, P E Postmus, C van Pottelsberghe, et al.

The Journal of Urology|August 1, 1989

Phase II study of recombinant interferon alpha-2a and vinblastine in advanced renal cell carcinomaJ H Schornagel, J Verweij, W W ten Bokkel Huinink, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998

Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trialC Grimaldi, H Bleiberg, F Gay, et al.

Pageof 11